Artificial Intelligence has suddenly gone from the fringes of science to being everywhere. So how did we get here? And where's this all heading? In this new series of Science Friction, we're finding out.
…
continue reading
المحتوى المقدم من Biotech2050 Podcast and Biotech 2050. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Biotech2050 Podcast and Biotech 2050 أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Revolutionizing Proteomics: Sujal Patel, Co-Founder & CEO of Nautilus, on Drug Development
MP3•منزل الحلقة
Manage episode 428363299 series 3379994
المحتوى المقدم من Biotech2050 Podcast and Biotech 2050. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Biotech2050 Podcast and Biotech 2050 أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Synopsis: Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development. Sujal shares his transition from tech to biotech, the formation of Nautilus with Parag Mallick, and their revolutionary approach using multi-affinity probes. The conversation highlights the importance of proteomics in drug discovery, the broad applications of their technology, and the significance of product-market fit and fiscal discipline in building a sustainable business. Biography: Sujal Patel is the co-founder of Nautilus Biotechnology, a life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to democratize access to the proteome and, in doing so, enable fundamental advancements across human health and medicine. Sujal founded Isilon Systems in 2001, a storage company built for the future of unstructured, file-based data. In 2006, Isilon completed one of the most successful initial public offerings of the year. EMC (since acquired by Dell) acquired Isilon in December 2010 for $2.6 Billion, the largest acquisition in EMC’s history. Sujal served as the president of EMC’s Isilon Storage Division from the acquisition until November 2012, driving significant revenue growth, market expansion, and organizational scale. Prior to EMC and Isilon, Sujal served in various engineering roles at RealNetworks, Inc., in part as the chief architect behind the company’s second-generation core media delivery system. Sujal holds nineteen patents in the areas of storage, networking, and media delivery and five patents for innovations related to the development of Nautilus Biotechnology’s technology. He is a well-known speaker on entrepreneurship and has received a variety of industry awards. Currently, Sujal serves on the board of directors at Qumulo and Rainier Scholars and helps direct the philanthropic efforts of his family’s foundation. He graduated from the University of Maryland College Park in 1996 with a degree in computer science.
…
continue reading
221 حلقات
MP3•منزل الحلقة
Manage episode 428363299 series 3379994
المحتوى المقدم من Biotech2050 Podcast and Biotech 2050. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Biotech2050 Podcast and Biotech 2050 أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Synopsis: Sujal Patel, co-founder and CEO of Nautilus Biotechnology, discusses their innovative work in proteomics and its impact on drug development. Sujal shares his transition from tech to biotech, the formation of Nautilus with Parag Mallick, and their revolutionary approach using multi-affinity probes. The conversation highlights the importance of proteomics in drug discovery, the broad applications of their technology, and the significance of product-market fit and fiscal discipline in building a sustainable business. Biography: Sujal Patel is the co-founder of Nautilus Biotechnology, a life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to democratize access to the proteome and, in doing so, enable fundamental advancements across human health and medicine. Sujal founded Isilon Systems in 2001, a storage company built for the future of unstructured, file-based data. In 2006, Isilon completed one of the most successful initial public offerings of the year. EMC (since acquired by Dell) acquired Isilon in December 2010 for $2.6 Billion, the largest acquisition in EMC’s history. Sujal served as the president of EMC’s Isilon Storage Division from the acquisition until November 2012, driving significant revenue growth, market expansion, and organizational scale. Prior to EMC and Isilon, Sujal served in various engineering roles at RealNetworks, Inc., in part as the chief architect behind the company’s second-generation core media delivery system. Sujal holds nineteen patents in the areas of storage, networking, and media delivery and five patents for innovations related to the development of Nautilus Biotechnology’s technology. He is a well-known speaker on entrepreneurship and has received a variety of industry awards. Currently, Sujal serves on the board of directors at Qumulo and Rainier Scholars and helps direct the philanthropic efforts of his family’s foundation. He graduated from the University of Maryland College Park in 1996 with a degree in computer science.
…
continue reading
221 حلقات
كل الحلقات
×مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.